Prittle Prattle News

pp news (3)
pp news (3)
Menu
Business

INR 400 Million Investment from Kotak Alts Fuels Zeroharm Sciences Expansion

February 18, 2026
Experiential Maths Learning Enters Classrooms as MagicMinds Launches Interactive Lab at Manaskriti School
Experiential Maths Learning Enters Classrooms as MagicMinds Launches Interactive Lab at Manaskriti School

Ashish Ranjan, Director, Kotak Alternate Asset Managers Limited, India, says early stage nutraceutical adoption offers long term growth potential

Mumbai, February 18, 2026: Kotak Alternate Asset Managers Limited, through its Kotak Life Sciences Fund I, has invested INR 400 million in Zeroharm Sciences, a plant based nutraceutical direct to consumer brand founded in 2020.
The capital infusion is intended to support operational scale up, brand development and expansion into new markets.

Ashish Ranjan, Director, Kotak Alternate Asset Managers Limited, India, said, “The Indian nutraceuticals market continues to benefit from favourable macroeconomic and demand drivers. Adoption remains at an early stage, offering significant long term growth potential. Zeroharm combines Ayurveda based knowledge with technology driven processes to deliver scalable preventive care solutions.”

Founded by Sachin Darbarwar, Zeroharm Sciences operates with integrated capabilities across extraction, formulation research and development, and manufacturing. The company distributes products through its own website, major e commerce platforms and quick commerce channels in India. It is also expanding its presence in the United States, United Kingdom and the Middle East.

Sachin Darbarwar, Co Founder and Chief Executive Officer, Zeroharm Sciences, India, said, “This investment marks a transition from early product validation to scaled growth. Partnering with Kotak Alts and Alkemi Growth Capital provides not only capital but long term institutional support. Their understanding of the healthcare and life sciences ecosystem aligns with our integrated model across extraction, formulation, research and manufacturing.”
Kotak Life Sciences Fund I focuses on early to growth stage investments within healthcare and life sciences businesses.
At Prittle PrattleNews, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.

Related Posts

1 of 186

1 Comment

  1. Pingback: ValueQuest Tristar Fund Corpus Revised to INR 2,000 Crore After Oversubscription

Leave A Reply

Your email address will not be published. Required fields are marked *

Today's Top Posts

Prittle Prattle News, indicates news that expresses virtuously, is one of the world’s most trusted, renowned, and fastest-growing online news portals.

Prittle Prattle News, indicates news that expresses virtuously, is one of the world’s most trusted, renowned, and fastest-growing online news portals.

Linkedin Instagram Facebook Twitter

Explore

Legal

Connect

© 2025 Prittle Prattle News. All rights reserved.

Prittle Prattle News, indicates news that expresses virtuously, is one of the world’s most trusted, renowned, and fastest-growing online news portals.

Prittle Prattle News, indicates news that expresses virtuously, is one of the world’s most trusted, renowned, and fastest-growing online news portals.

Linkedin Instagram Facebook Twitter

Explore

Legal

Connect

© 2025 Prittle Prattle News. All rights reserved.